Staying power of coronavirus antibodies bodes well for COVID-19 vaccines, study says
LOS ANGELES TIMES – A comprehensive study from Iceland revealed that natural antibodies remained stable for four months, longer than was first thought. HPM’s Derek Angus (BCHS ’92), UPMC’s critical care chief, said that “will be encouraging for people working on vaccines.” He added that the infection fatality rate of 0.3 percent is in keeping with recent estimates here in the U.S.
Read full story
9/01/2020